MEDIVIR AB
119Patents
71Active
119Granted
51Portfolio score
Filing activity: Jan 22, 1988 → May 3, 2022 · 29 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9828408B2 | HCV polymerase inhibitors | Chemistry; Metallurgy | 50 | Active |
| US5593993A | Method for inhibition of HIV related viruses | Chemistry; Metallurgy | 47 | Expired |
| US8552021B2 | Phosphoramidate derivatives of nucleosides | Human Necessities | 44 | Active |
| US9481703B2 | HCV polymerase inhibitors | Chemistry; Metallurgy | 39 | Active |
| US9540411B2 | HCV polymerase inhibitors | Chemistry; Metallurgy | 39 | Active |
| US6458772B1 | Prodrugs | Chemistry; Metallurgy | 35 | Expired |
| US8481510B2 | Uracyl spirooxetane nucleosides | Chemistry; Metallurgy | 31 | Active |
| US7666856B2 | Antiviral nucleosides | Human Necessities | 29 | Active |
| US8399429B2 | Uracyl cyclopropyl nucleotides | Human Necessities | 29 | Active |
| US5215971A | Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides | Chemistry; Metallurgy | 29 | Expired |
| US9012428B2 | Uracyl spirooxetane nucleoside phosphoramidates | Human Necessities | 27 | Active |
| US5576429A | 5-substituted pyrimidine nucleosides and nucleotides | Chemistry; Metallurgy | 27 | Expired |
| US5446029A | Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides | Chemistry; Metallurgy | 25 | Expired |
| US5473063A | Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues | Chemistry; Metallurgy | 24 | Expired |
| US8933052B2 | Uracyl spirooxetane nucleosides | Chemistry; Metallurgy | 24 | Active |
| US8431588B2 | Cyclopropyl polymerase inhibitors | Human Necessities | 23 | Active |
| US7601702B2 | Dutpase Inhibitors | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7608590B2 | HCV NS-3 serine protease inhibitors | Chemistry; Metallurgy | 21 | Expired |
| US7700552B2 | Macrocyclic inhibitors of hepatitis C virus | Chemistry; Metallurgy | 18 | Active |
| US5714503A | Compounds and methods for inhibition of HIV and related viruses | Chemistry; Metallurgy | 18 | Expired |
| US5849769A | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection | Chemistry; Metallurgy | 17 | Expired |
| US5409906A | .alpha. nucleoside compounds and a method for treating HBV using said compounds | Chemistry; Metallurgy | 17 | Expired |
| US5658907A | Compounds and methods for inhibition of HIV and related viruses | Chemistry; Metallurgy | 17 | Expired |
| US6337324B1 | Pharmaceutical combination | Human Necessities | 14 | Expired |
| US8349869B2 | Macrocylic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 12 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.